Inactive Instrument

Calendar Evogene Ltd TEL AVIV STOCK EXCHANGE

Equities

IL0011050551

Chart calendar Evogene Ltd

de42a6a79fc95313e.0M-UlV18iS-tOE0HUONHazXpecv5H3SJ8Dwok2qsAto.vaj8pRY3yEvUSixTZ7I0Il2vKPqfUzX9oWkd3yfmRZTmhq2kbQbmYN9UPg~82a5755b5b769fb04d7c22294b0ebacc

Upcoming events on Evogene Ltd

2024-05-27 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-05 Q4 2024 Earnings Release (Projected)

Past events on Evogene Ltd

2024-03-16 Roth Conference
2024-03-07 09:00 am Q4 2023 Earnings Call
2024-03-07 07:00 am Q4 2023 Earnings Release
2024-02-01 11:15 am Microbiome Movement Drug Development Summit
2024-01-30 10:30 am Microbiome Movement Drug Development Summit
2024-01-07 JPMorgan Healthcare Conference
2023-11-15 09:00 am Q3 2023 Earnings Call
2023-11-15 07:00 am Q3 2023 Earnings Release
2023-08-17 09:00 am Q2 2023 Earnings Call
2023-08-17 07:00 am Q2 2023 Earnings Release
2023-05-18 09:00 am Q1 2023 Earnings Call
2023-05-18 07:00 am Q1 2023 Earnings Release
2023-03-21 10:40 am Pharmabiotics Conference
2021-05-26 09:00 am Q1 2021 Earnings Call
2021-05-26 07:00 am Q1 2021 Earnings Release
2021-04-21 Jefferies Microbiome-based Therapeutics Summit
2021-04-21 09:00 am Investor & Analyst Day
2021-03-03 09:00 am FY 2020 Earnings Call
2021-03-03 07:00 am FY 2020 Earnings Release
2021-01-23 02:00 pm Crohn & Colitis Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00


1,04
0,00
-
0,93
0,61
51.47%
1,68
1,57
6.69%
5,64
5,54
1.86%
EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-22,0
-21,8
-0.92%
EBIT
Million USD
Released
Forecast
Spread
0,00


-24,8
-24,0
-3.39%
-31,0
-28,9
-7%
-26,9
-31,8
15.39%
-26,5
-26,4
-0.49%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-26,2
-23,0
-13.8%
-30,4
-30,6
0.52%
-29,8
-34,0
12.49%
-26,0
-26,0
0.09%
Net income
Million USD
Released
Forecast
Spread
-18,1


-23,4
-23,0
-1.63%
-27,8
-29,0
4.18%
-26,6
-31,2
14.73%
-23,9
-25,0
4.59%
EPS
USD
Released
Forecast
Spread
-0,70


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Announcement Date04/03/2003/03/2110/03/2209/03/2307/03/24

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,15
0,11
34.82%
0,31
0,17
85.48%
0,24
0,31
-23.3%
0,31
0,22
41.39%
0,47
0,28
65.25%
0,66
0,55
20%
0,64
0,69
-6.42%
0,65
0,89
-26.1%
3,77
1,18
218.34%
0,58
0,48
21.68%

3,38


3,13


8,03


5,78

EBITDA
Million USD
Released
Forecast
Spread


















-5,74
-5,95
3.58%
-6,45
-6,05
-6.66%
-2,98
-6,30
52.75%
-6,85
-6,33
-8.33%

-3,55


-5,33


-3,50


-5,35

EBIT
Million USD
Released
Forecast
Spread
-8,56
-7,67
-11.56%
-8,69
-8,71
0.21%
-8,06
-8,09
0.41%
-8,01
-8,21
2.49%
-7,10
-8,70
18.38%
-3,78
-8,75
56.78%
-6,80
-7,85
13.37%
-7,90
-7,98
0.93%
-4,18
-7,67
45.46%
-7,63
-7,49
-1.88%

-4,85


-6,63


-4,80


-6,65

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,34
-7,61
-9.53%
-8,09
-8,57
5.6%
-9,10
-8,75
-4.08%
-9,72
-8,29
-17.17%
-7,16
-8,38
14.56%
-3,78
-8,00
52.8%
-7,03
-7,10
1.04%
-7,76
-7,98
2.73%
-3,86
-7,64
49.42%
-7,34
-7,34
-0.05%

-4,85


-6,63


-4,80


-6,65

Net income
Million USD
Released
Forecast
Spread
-7,61
-7,21
-5.48%
-7,37
-8,16
9.64%
-9,11
-7,61
-19.72%
-8,82
-7,71
-14.45%
-6,54
-8,46
22.69%
-3,00
-8,28
63.79%
-6,27
-7,60
17.43%
-7,02
-7,29
3.66%
-3,98
-7,21
44.77%
-6,60
-7,09
6.86%

-4,35


-6,13


-4,30


-6,15

Announcement Date17/11/2110/03/2226/05/2231/08/2217/11/2209/03/2318/05/2317/08/2315/11/2307/03/24----